A phase 1, open label, dose escalation study to investigate...

  • Main
  • 2017 / 3
  • A phase 1, open label, dose escalation study to investigate...
Investigational New Drugs 2017 / 3

A phase 1, open label, dose escalation study to investigate the safety, tolerability, and pharmacokinetics of MG1102 (apolipoprotein(a) Kringle V) in patients with solid tumors

Kim, Gun Min, Reid, Tony, Shin, Sang Joon, Rha, Sun Young, Ahn, Joong Bae, Lee, Sung Sil, Chung, Hyun Cheol
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Investigational New Drugs
DOI:
10.1007/s10637-017-0460-1
Date:
March, 2017
File:
PDF, 1.40 MB
english, 2017
Conversion to is in progress
Conversion to is failed